Wuhu Zhuorui Innovation Investment Management Center (Limited Partnership), Yang Hong, and Zhou Nanxin agreed to acquire 4.87% stake in Changchun Changsheng Life Sciences Limited from Huang Qili for approximately CNY 130 million on October 24, 2014. Wuhu Zhuorui Innovation Investment Management Center (Limited Partnership) will acquire 3.36% stake for CNY 86.25 million, Yang Hong will acquire 1.17% stake for CNY 30 million, and Zhou Nanxin will acquire 0.34% stake for CNY 8.75 million. Changchun Changsheng Life Sciences Limited reported total assets of CNY 1.56 billion, total owner's equity of CNY 1 billion, revenue of CNY 622.62 million, operating profit of CNY 236.68 million and net profit of CNY 207.86 million as of December 31, 2014.
End-of-day quote
Other stock markets
|
||
- CNY | - |
1st Jan change | Capi. | |
---|---|---|
0.00% | 106M | |
-2.29% | 89.87B | |
-3.95% | 37.57B | |
+63.05% | 26.47B | |
-22.14% | 14.25B | |
-7.96% | 12.99B | |
-9.33% | 11.93B | |
-46.33% | 10.84B | |
+5.77% | 9.11B | |
-17.66% | 7.32B |
- Stock Market
- Equities
- 002680 Stock
- News Changsheng Bio-technology Co Ltd
- Wuhu Zhuorui Innovation Investment Management Center (Limited Partnership), Yang Hong, and Zhou Nanxin acquired 4.87% stake in Changchun Changsheng Life Sciences Limited from Huang Qili for approximately CNY 130 million.